Acrivon Therapeutics (ACRV) announced the U.S. Food and Drug Administration, FDA, has granted Breakthrough Device designation, BDD, for the ...

The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...

OTTAWA, ON, Jan. 14, 2025 /CNW/ - APS Aerospace Corp. is pleased to announce that it has joined the ACR Group which is comprised of several companies, focused on Aviation, Government, Defense ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Accenture has agreed to acquire Staufen AG, a Germany-based management consulting firm, and its subsidiaries1. The acquisition will expand Accenture's capabilities to drive operational excellence and ...

Genetic variants linked to autism are associated with structural differences in neonatal white matter, particularly increased ...